ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.933,62
1,56%
S&P 500
6.047,15
0,81%
Dow Jones
44.782,00
-0,29%
Euro vs US Dollar
1,0491
-0,09%
Bitcoin
96.147,59
0,30%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Onconova Therapeutics Inc (ONTX)

  7. Onconova Therapeutics Inc (ONTX) News

ONTX

Onconova Therapeutics (ONTX)

Onconova Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ONTX
DatumZeitQuelleÜberschriftSymbolFirma
09/02/202423h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
09/02/202423h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
08/02/202422h09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
27/10/202322h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
27/10/202322h35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
29/09/202323h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
15/08/202322h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202323h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202323h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202323h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202323h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202323h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202323h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202323h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
14/08/202323h28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONTXOnconova Therapeutics Inc
10/08/202323h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
04/08/202322h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
04/08/202322h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
21/07/202322h50Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONTXOnconova Therapeutics Inc
21/07/202322h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
12/07/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONTXOnconova Therapeutics Inc
30/06/202322h46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONTXOnconova Therapeutics Inc
13/06/202322h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
07/06/202322h31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONTXOnconova Therapeutics Inc
15/05/202323h29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONTXOnconova Therapeutics Inc
09/05/202314h36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONTXOnconova Therapeutics Inc
30/03/202322h47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ONTXOnconova Therapeutics Inc
15/03/202300h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
14/03/202323h49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
14/03/202323h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ONTX

Kürzlich von Ihnen besucht

BIT
F38573
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€